When it comes to GSK’s new dealmaking strategy of trying to outdo established blockbusters, CEO Luke Miels has told Fierce that oncology may offer the most tempting targets. | When it comes to GSK’s ...

In GSK’s first quarter with Luke Miels as CEO, the company’s flagship shingles vaccine Shingrix set a new quarterly sales ...

By Bhanvi Satija LONDON, April 29 (Reuters) - GSK posted first-quarter profit and sales above analyst expectations on ...

By Bhanvi Satija LONDON, April 29 (Reuters) - British drugmaker GSK reported first-quarter profit and sales above analysts' ...

Strong first-quarter results under new GSK CEO Luke Miels on Wednesday failed to impress investors, who raised concerns ‌that ...

GSK has had a solid start to 2026, with revenues rising ahead of analyst expectations in the first full quarter under new ...

(Reuters) -GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on Monday, a surprise switch as the British firm looks to rev up its ...

Emma Walmsley has served as CEO of GlaxoSmithKline since 2017. From the Philadelphia Business Journal. GSK is making a change at the top. The London-based Big Pharma company, which has major ...

GSK CEO Emma Walmsley will be stepping aside after nine years. Shares of GSK rallied on Monday after the U.K. pharmaceutical giant turned to an insider to become its next CEO. Luke Miels, chief ...

By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker will aim to lift sales growth and speed up work on new medicines in its ...

GSK named Luke Miels to succeed Emma Walmsley as the British drugmaker's chief executive. The U.K. pharmaceuticals giant said Monday that Miels, currently GSK's chief commercial officer, will take on ...